Kwality Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Kwality Pharmaceuticals Ltd. on BSE

Load latest

Kwality Pharmaceuticals Ltd.

06 Feb 2024

813.15

-0.20%

Result

Kwality Pharmaceuticals Ltd - 539997 - Submission Of Unaudited Financial Results For The Quarter And Nine …

BSE India

Submission of Unaudited financial results for the quarter and nine months ended 31-12-2023

pdf

Kwality Pharmaceuticals Ltd.

06 Feb 2024

813.15

-0.20%

Board Meeting

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Outcome for Unaudited Financial Results For The Quarter …

BSE India

Pursuant to Regulation 30 & 33 read with clause 4 (h) of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulation, 2015 ('Listing Regulations'), this is to inform you that Board of Directors in its meeting held today i.e., February 06, 2024, have inter-alia , considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December, 2023 along with Limited Review Report issued by Statutory Auditors of the Company. A copy of the same is enclosed herewith.

pdf

Kwality Pharmaceuticals Ltd.

25 Jan 2024

813.15

-0.20%

Board Meeting

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Intimation for Approval Of The Standalone And Consolidated …

BSE India

Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and Nine months ended December 31, 2023 along with Limited Review Report.

pdf

Kwality Pharmaceuticals Ltd.

15 Jan 2024

813.15

-0.20%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Reg. 74(5)

pdf

Kwality Pharmaceuticals Ltd.

28 Dec 2023

813.15

-0.20%

SAST

Kwality Pharmaceuticals Ltd - 539997 - Closure of Trading Window

BSE India

Trading Window Closure

pdf

Kwality Pharmaceuticals Ltd.

10 Nov 2023

813.15

-0.20%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

NEWSPAPER PUBLICATIONS OF FINANCIAL RESULTS FOR Q.E. 30-09-2023

pdf

Kwality Pharmaceuticals Ltd.

04 Nov 2023

813.15

-0.20%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of …

BSE India

Related Party Transactions for the half year ended 30-09-2023

pdf

Kwality Pharmaceuticals Ltd.

04 Nov 2023

813.15

-0.20%

Result

Kwality Pharmaceuticals Ltd - 539997 - Submission Of Unaudited Financial Results For The Quarter And Half …

BSE India

UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30-09-2023

pdf

Kwality Pharmaceuticals Ltd.

04 Nov 2023

813.15

-0.20%

Board Meeting

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Outcome for Submission Of Unaudited Financial Results For …

BSE India

Pursuant to Regulation 30 & 33 read with clause 4 (h) of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulation, 2015 ('Listing Regulations'), this is to inform your that Board of Directors in its meeting held today i.e., November 04, 2023, have inter-alia , considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2023, along with Limited Review Report issued by Statutory Auditors of the Company. A copy of the same is enclosed herewith.

pdf

Kwality Pharmaceuticals Ltd.

17 Oct 2023, 01:45PM

813.15

-0.20%

Board Meeting

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Intimation for Approving The Unaudited Standalone And Consolidated …

BSE India

Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2023.

pdf

Is Kwality Pharmaceuticals Ltd. worth buying?

56 Votes:

Buy 71.43%

Sell 16.07%

Hold 12.5%